General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0SQBPH
ADC Name
CMPXC
Synonyms
CMPXC
   Click to Show/Hide
Organization
The Catholic University of Korea.; Northwestern University.
Drug Status
Investigative
Structure
Antibody Name
Cetuximab
 Antibody Info 
Antigen Name
Epidermal growth factor receptor (EGFR)
 Antigen Info 
Payload Name
Chlorin e6 (Ce6)
 Payload Info 
Linker Name
Mal-PX linker
 Linker Info 
Conjugate Type
Random conjugation through reduced inter-chain cysteines.
General Information of The ADMET Data Related to This ADC(2027 Update)
Absorption
Click To Hide/Show 2 Absorption Data Related to This Level
Standard Type Value Units Description Reference
Area Under the Concentration-Time Curve (AUC) 5±0.15 mg&#42h/L
Pharmacokinetic parameters of mice after IV injection of CMPXC.
[1]
Maximum Observed Concentration (Cmax) 1.45±0.6 mg/L
Pharmacokinetic parameters of mice after IV injection of CMPXC.
[1]
Distribution
Click To Hide/Show 1 Distribution Data Related to This Level
Standard Type Value Units Description Reference
Area Under the Concentration-Time Curve (AUC) 5±0.15 mg&#42h/L
Pharmacokinetic parameters of mice after IV injection of CMPXC.
[1]
Metabolism
Click To Hide/Show 1 Metabolism Data Related to This Level
Standard Type Value Units Description Reference
Area Under the Concentration-Time Curve (AUC) 5±0.15 mg&#42h/L
Pharmacokinetic parameters of mice after IV injection of CMPXC.
[1]
Excretion
Click To Hide/Show 2 Excretion Data Related to This Level
Standard Type Value Units Description Reference
Area Under the Concentration-Time Curve (AUC) 5±0.15 mg&#42h/L
Pharmacokinetic parameters of mice after IV injection of CMPXC.
[1]
Elimination Half-Life (t1/2) 0.63±0.43 h
Pharmacokinetic parameters of mice after IV injection of CMPXC.
[1]
References
Ref 1 Synergistic Approach of Antibody-Photosensitizer Conjugate Independent of KRAS-Mutation and Its Downstream Blockade Pathway in Colorectal Cancer